Schwartz Jonathan David
See Remarks
Schwartz Jonathan David has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 20, 2025.
On the most recent filing, Schwartz Jonathan David is listed as See Remarks at ROCKET PHARMACEUTICALS, INC. Inside the rolling window, Schwartz Jonathan David reported no open-market purchases and 1 open-market sale totaling $8K in RCKT.
Companies traded
Other insiders at RCKT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Schwartz Jonathan David made?
Schwartz Jonathan David has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Schwartz Jonathan David trade?
Schwartz Jonathan David has filed SEC Form 4 disclosures for 1 company, including RCKT.
When was Schwartz Jonathan David's most recent SEC Form 4 filing?
Schwartz Jonathan David's most recent SEC Form 4 filing on Tracefour is dated Nov 20, 2025.
What is Schwartz Jonathan David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Schwartz Jonathan David is listed as See Remarks.
What is Schwartz Jonathan David's total buy and sell value in the current window?
Inside the rolling retention window, Schwartz Jonathan David bought $0 and sold $8K based on SEC Form 4 filings.
What was Schwartz Jonathan David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,545 RCKT shares on 2025-11-18, worth $8K, per SEC Form 4 filings.